Science & Tech

After COVID vaccines, time to use mRNA tech against other infectious diseases

After COVID Vaccines, Time to Use mRNA Tech Against Other Infectious Diseases | GZERO Media

Using mRNA technology to develop effective COVID vaccines has been a scientific breakthrough.

But that's just the tip of the iceberg, Melanie Saville, head of vaccine development at the Coalition for Epidemic Preparedness Innovations, said during a livestream discussion on equitable vaccine distribution hosted by GZERO Media in partnership with the Bill & Melinda Gates Foundation. "

There's still a lot that should be done with the technology moving forward" on other infectious diseases like HIV, malaria, or TB. Still, she said that vaccines are only the beginning.

Local manufacturing and distribution is as important — as is future equitable access to the mRNA tech itself.

More For You

- YouTube

At the 2026 World Bank/IMF Spring Meetings, former Egyptian Minister of Planning, Economic Development & International Cooperation Rania Al-Mashat speaks with GZERO’s Tony Maciulis about a global economy increasingly shaped by geopolitical fragmentation and rising uncertainty.

- YouTube

In Iran, a shooting war has given way to a fragile ceasefire and a high-stakes standoff in the Strait of Hormuz, with the global economy hanging in the balance. Iran now holds effective control over a critical oil chokepoint, says Eurasia Group energy analyst Gregory Brew, while the US enforces its own blockade to try to squeeze Iran.